Overview

Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin

Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of rosuvastatin and/or simvastatin in healthy male subjects and female subjects not of child-bearing potential.
Phase:
Phase 1
Details
Lead Sponsor:
Madrigal Pharmaceuticals, Inc.
Collaborator:
Celerion
Treatments:
Rosuvastatin Calcium
Simvastatin